124 related articles for article (PubMed ID: 12676257)
1. CD44v6 in developing, dysplastic and malignant oral epithelia.
Rautava J; Soukka T; Inki P; Leimola-Virtanen R; Saloniemi I; Happonen RP; Heikinheimo K
Oral Oncol; 2003 Jun; 39(4):373-9. PubMed ID: 12676257
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
[TBL] [Abstract][Full Text] [Related]
3. [Alteration of CD44v3 and CD44v6 expression in oral premalignant epithelia].
Gao Y; Liu J; Pang S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):286-8. PubMed ID: 11776894
[TBL] [Abstract][Full Text] [Related]
4. CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues.
Bahar R; Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Dec; 26(6):443-6. PubMed ID: 9418147
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
6. [Expression of CD44 variant 6 and its metastatic potential in squamous cell carcinoma of the oral cavity].
Kunishi M; Kayada Y; Tsumura M; Yoshiga K; Takada K
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1045-8. PubMed ID: 8687219
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas.
Christensen ME; Therkildsen MH; Hansen BL; Albeck H; Hansen GN; Bretlau P
Eur Arch Otorhinolaryngol; 1992; 249(5):243-7. PubMed ID: 1524803
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions.
Heyden A; Huitfeldt HS; Koppang HS; Thrane PS; Bryne M; Brandtzaeg P
J Oral Pathol Med; 1992 Jan; 21(1):7-11. PubMed ID: 1375644
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
11. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
Torres-Rendon A; Roy S; Craig GT; Speight PM
Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
[TBL] [Abstract][Full Text] [Related]
12. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma.
Wakulich C; Jackson-Boeters L; Daley TD; Wysocki GP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):573-9. PubMed ID: 12075207
[TBL] [Abstract][Full Text] [Related]
14. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H
J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas.
Sawant SS; Vaidya Mm; Chaukar DA; Alam H; Dmello C; Gangadaran P; Kannan S; Kane S; Dange PP; Dey N; Ranganathan K; D'Cruz AK
Oral Dis; 2014 Jul; 20(5):453-65. PubMed ID: 23865921
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan.
Fong Y; Chou SJ; Hung KF; Wu HT; Kao SY
J Chin Med Assoc; 2008 Mar; 71(3):123-7. PubMed ID: 18364263
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma.
Singh BB; Chandler FW; Whitaker SB; Forbes-Nelson AE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jun; 85(6):692-8. PubMed ID: 9638703
[TBL] [Abstract][Full Text] [Related]
18. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity.
Devoll RE; Li W; Woods KV; Pinero GJ; Butler WT; Farach-Carson MC; Happonen RP
J Oral Pathol Med; 1999 Mar; 28(3):97-101. PubMed ID: 10069535
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
